Terumo (OTCMKTS:TRUMY) Sees Strong Trading Volume – Time to Buy?

Terumo Corp. (OTCMKTS:TRUMY) saw unusually-high trading volume on Thursday . Approximately 2,049,380 shares changed hands during mid-day trading, an increase of 303% from the previous session’s volume of 508,467 shares.The stock last traded at $12.73 and had previously closed at $12.67.

Terumo Stock Up 0.6%

The company has a 50-day moving average price of $14.04 and a 200 day moving average price of $15.82. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.51 and a quick ratio of 1.46. The firm has a market capitalization of $18.80 billion, a PE ratio of 21.98 and a beta of 0.74.

Terumo (OTCMKTS:TRUMY) last issued its quarterly earnings results on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Terumo had a return on equity of 9.13% and a net margin of 11.74%.The company had revenue of $1.94 billion during the quarter, compared to the consensus estimate of $1.82 billion.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.